性行为指导的个体化治疗对血精症治疗的作用探讨（附89例报告）

目的探讨性行为指导的个体化治疗在非肿瘤性血精症治疗中的作用。方法自2005年2月—2008年4月,89名非肿瘤性血精症患者随机分为常规治疗组(32例)和个体化治疗组(57例)。常规治疗组予以抗生素、安络血、维生素C口服。个体化治疗组根据精液、前列腺液常规分析及前列腺液或精液细菌培养,分为感染性和非感染性血精症,通过对患者的性行为指导,予以性行为指导的个体化治疗,并随访观察治疗效果。结果个体化治疗组治愈率和复发率为95.7%和3.5%,常规治疗组的治愈率和复发率为60.9%和9.4%。经x2检验,治疗结果有显著性差异,个体化治疗组优于常规治疗组(P<0.05)。结论性行为指导的个体化治疗非肿瘤性血精症疗效显著,具有较好的临床价值。

Effect of individualized treatment with sexual behavior instruction on hemospermia (report of 89 cases)

Objective To investigate the effect of individualized treatment with sexual behavior instruction on nontumorous hemospermia. Methods From Feb of 2005 to Apr of 2008, 89 patients with nontumorous hemospermia were divided randomly into conventional therapy group (32 cases) and individualized treatment group (57 cases). In conventional therapy groups, the patients were treated with antibiotics, carbazochrome and vitamin C. Patients in individualized treatment groups were further subdivided into infection group (39 cases) and non-infection group (18 cases) based on the results of routine analysis and bacterial culture of prostatic fluid/semen. Then patients in individualized treatment group received sexual behavior instruction. The effect of treatment was followed up. Results The recovery rate and recurrence rate were 95.7% and 3.5% in individualized treatment groups, and 60.9% and 9.4% in conventional therapy groups, respectively. A significant difference in recovery rate or recurrence rate was found between individualized treatment group and conventional therapy group (P<0.05). Conclusion Individualized treatment with sexual behavior instruction showed great advantage in treatment of nontumorous hemospermia and promising value in clinic practice.